期刊文献+

脑卒中溶栓后出血性转化与临床预后研究 被引量:2

Hemorrhagic Transformations and Prognoses in Stroke Patients with Thrombolysis
原文传递
导出
摘要 目的阐明中国汉族人急性脑卒中溶栓后出血性转化与临床预后的关系。方法采用二分类Logistic回归回顾性分析脑卒中溶栓队列出血性转化和预后关系。结果共纳入102例患者,男性44例(43.1%),女性58例(56.9%);年龄中位数73岁;溶栓无出血转化73例(74.5%),梗塞性出血12例(12.2%),脑实质性出血13例(13.3%)。预后良好44例(43.6%),预后不良57例(56.4%)。溶栓后ASPECT评分可预示出血性转化(OR0.15)和预后不良(OR0.20);血肌钙蛋白水平同样预示出血转化(OR27.42)和不良结局(OR12.16)。其他独立影响因素为脉搏数(OR2.18)和NIHSS评分(OR2.00),但出血转化本身与预后无相关性。结论溶栓后低ASPECT评分、基线高血肌钙蛋白水平、高NIHSS评分和高脉搏计数可以预测溶栓后3个月不良预后,出血性转化可能与预后无关。 Objective To clarify the relations of hemorrhagic transformations and functional outcomes in Chinese stroke patients with thrombolysis. Method A retrospective cohort study with logistic regression analyses was performed. Results A total of 102 patients were included. Forty-four (43.1%) were males and 58(56.9%) were females. The median of age was 73. No hemorrhagic transformation was observed in 73(74.5%) patients, while hemorrhagic infarction in 12(12.2%) and parenchymal hemorrhage in 13 ( 13.3% ). Forty-four (43.1%) patients got favorable outcome and 57 (56.4%) with unfavorable one. Lower ASPECT scale after thrombolysis(OR=0.15 and 0.20) and higher baseline troponin level(OR= 27.42 and 12.16) independently correlated with hemorrhagic transformation and unfavorable outcomes, respectively. Other predictors of unfavorable outcome were high NIHSS scale (OR=2.00) and high pulse count (OR=2.18). Conclusions Lower ASPECT scale after thrombolysis, higher serum troponin level, higher NIHSS scale and high pulse count might independently predict 90-day unfavorable outcome in Chinese patients with thrombolysis. Hemorrhagic transformation might not correlate with functional outcome.
出处 《热带医学杂志》 CAS 2012年第11期1316-1319,1341,共5页 Journal of Tropical Medicine
关键词 脑卒中 阿替普酶 出血性转化 stroke Aheplase hemorrhagic transformation
  • 相关文献

参考文献20

  • 1The National Institute or Neurological Disorders and Stroke rtPA Stroke Study Group.Tissue plasminogen activator for acute ischemic: slroke[J]. N F:ngl J Med, 1995,333 (24) : 1581-1587.
  • 2Thorvaldsen P, Asplund K, Kuulasmaa K ,el al.Stroke incidence. case futality , and mortality in the WHO MONICA project. Worltl Health Organization Moniloring Trends and Determinants in Cardiovascular Diseasej J ).Strokc, 1995, 26( 3) : 361-367.
  • 3Kidwell CS, Warach S.Acute ischemic cerebrovascular syndrome: diagnostic criteria [J]. Stroke, 2003,34 ( 12) : 2995- 2998.
  • 4Petitti N.The hyperdense middle cerebral artery sign[J]. Radiology, 1998,208(3):687-688.
  • 5Warlow C.A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project, 1981-1986[J].J Neurol Neurosurg Psychiatry,2012,83(6):579.
  • 6Adams HJ, Bendixen RH, Kappelle LJ, et al.Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST.Trial of Org 10172 in Acute Stroke Treatment [J ].Stroke, 1993, 24(1): 35-41.
  • 7Larrue V, von Kummer R. Muller A, et al. Risk Ii.ctors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)[J].Stroke,200I,32(2) :438-441.
  • 8Barber PA, Demchuk AM, Zhang J, el al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score [J]. Lancet, 2000, 355 (9216) : 1670-1674.
  • 9Suiter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials [J ].Stroke, 1999,30 (8): 1538-1541.
  • 10Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of II cerebral infurct , relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort [J]. St roke, 1999, 30 ( I I ) : 2280- 2284.

二级参考文献36

  • 1<脑卒中综合规范临床(内科)诊治研究方案>协作组.规范治疗急性脑卒中显著降低患者住院病死率[J].中华神经科杂志,2005,38(1):17-21. 被引量:74
  • 2Touze E, Mas JL, Rother J, et al. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack : results from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Stroke, 2006, 37: 2880-2885.
  • 3Wardlaw JM, del Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, 3: CD000213.
  • 4Sacco RL, Chong JY, Prabhakaran S. Experimental treatments for acute ischaemie stroke. Lancet, 2007, 369:331-341.
  • 5Davalos A, Castillo J, Alvarez-Sabin J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke, 2002, 33 : 2850-2857.
  • 6Albers GW, Goldstein LB, Hall D, et al. Aptiganel Acute Stroke Investigators. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA, 2001, 286:2673-2682.
  • 7Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic stroke. N Engl J Med, 2006, 354: 5884500.
  • 8Ly JV, Zava|a JA, Donnan GA. Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke. Expert Opin Pharmacother, 2006, 7 : 1571-1581.
  • 9Hankey GJ. Neuroprotection for acute ischaemic stroke: hope reignited. Lancet Neurol, 2006, 5:287-288.
  • 10Ginsberg MD, Palesch YY, Hill MD. The ALIAS (Albumin In Acute Stroke ) Phase Ⅲ randomized multicentre clinical trial: design and progress report. Biochem Soc Trans, 2006, 34 Pt 6: 1323-1326.

共引文献98

同被引文献17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部